New M&A Boot Camp (2023-2024 Ed.) – Webinar Premiering October 17, 2023

Leading Professionals to Teach About M&A Boot Camp

Financial Poise Webinars™ announces “The M&A Process,” a webinar premiering  October 17th at 1:00 PM CST. This webinar is co-produced by West LegalEdCenter™ and part of the “M&A Boot Camp 2023” series. It will feature Robert Londin (Jaspan Schlesinger LLP); Michael Weis (Firsel Ross & Weis); Jeremy Waitzman (Much Shelist, P.C.) and Phil Buffington (Adams & Reese LLP).

This webinar will discuss all these steps from a macro perspective so that you can see the forest for the trees, but does not do a deep dive into any single topic. Think of this webinar as a road map or timeline for a typical deal.

Buying, selling, or merging a company typically follows a similar set of steps from deal to deal. The amount of time each step takes varies but the order of the steps is fairly uniform because the steps follow a certain logic: before the parties share meaningful information, they should sign a confidentiality agreement (a/k/a “non-disclosure agreement,” or “NDA”); once a baseline amount of information is known by the would-be buyer, it commonly presents a letter of intent or term sheet to the target or its owner, which serves as an outline for a deal but does not necessarily bind the parties to consummate the transaction; additional due diligence and the negotiation, drafting and signing of definitive documents comes next. The parties then obtain any needed regulatory and/or contractual third party approvals; followed by closing; and finally by post-closing tasks. This webinar will discuss all these steps from a macro perspective so that you can see the forest for the trees, but does not do a deep dive into any single topic. Think of this webinar as a road map or timeline for a typical deal.

Learn More or Register:
https://westlegaledcenter.com/program_guide/course_detail.jsf?courseId=100299230.

Note: If you or your firm are subscribed to West LegalEdCenter™, this webinar is included in your subscription at no additional cost.